GL
KITE

GLG LLC’s Kite Pharma, Inc. KITE Stock Holding History

GLG LLC’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,702
Closed -$1.38M – 588
2016
Q4 		$1.38M Buy
30,702
+1,952
+7% +$95.8K 0.1% 226
2016
Q3 		$1.61M Buy
28,750
+3,750
+15% +$209K 0.11% 203
2016
Q2 		$1.25M Buy
+25,000
New +$1.23M 0.09% 223
2015
Q4 		– Sell
-109,031
Closed -$6.07M – 628
2015
Q3 		$6.07M Sell
109,031
-25,459
-19% -$1.6M 0.15% 160
2015
Q2 		$8.2M Buy
134,490
+79,685
+145% +$4.55M 0.17% 149
2015
Q1 		$3.16M Buy
54,805
+47,305
+631% +$3.17M 0.09% 248
2014
Q4 		$433K Buy
+7,500
New +$316K 0.01% 558

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

GLG LLC's KITE Position: Q1 2017 in Review

GLG LLC sold out of Kite Pharma, Inc. (KITE) in Q1 2017, closing a stake of 30,702 shares — an estimated $1.38M sold.

GLG LLC first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $8.2M in Q2 2015. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

  • GLG LLC reported no remaining Kite Pharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • GLG LLC sold 30,702 Kite Pharma, Inc. shares in Q1 2017, an estimated $1.38M.
  • GLG LLC first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
  • GLG LLC's Kite Pharma, Inc. position peaked at $8.2M in Q2 2015.
  • 209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on GLG LLC's 13F filing for Q1 2017, filed 15 May 2017.